Edward Jenner developed the Smallpox vaccine sometime around 1796 with minimal technology; with the technology that...

Edward Jenner developed the Smallpox vaccine sometime around 1796 with minimal technology; with the technology that we have now, why we are not developing more vaccines such as HIV? write in APA form 6th edition answer should contain a minimum of 200 words

Solutions

Expert Solution

The illness is the main reason for the healthcare service to be accessed for. The type of infection in 16th century is quite different from the 21st century infection in its virulence, incidence and prevalence .It was comparatively little challenging to discover a new medicine or a vaccine in earlier days with fewer technology . Besides the advanced growth and development with technology in healthcare the innovation for new vaccines are still a challenging task. The HIV infection caused by the virus is capable of changing its genetic nature which makes the scientist or researchers to segregate the desired genetic structures (commonly called as the DNA structure) impossible .If this is not done then it is not possible to innovate a vaccine. Moreover if a president infected with this virus the patient suffers life long and dies out of it. This is not the case in other infection where patient 's immune response happens and an antibody is developed. Therefore the innovation of HIV vaccines are still under process .

Nightingale answered 1 year ago

Next > < Previous

Related Solutions

In the early 1700's Edward Jenner demonstrated and was credited with the concept of vaccination. the...

In the early 1700's Edward Jenner demonstrated and was credited with the concept of vaccination. the theory/mechanism surrounding how the immunity to smallpox was achieved is referred to as "cross reactivity. Explain why we don't see much of this anymore or why it might not be exploited more.

Quiz 2 Hippocrates Thomas Sydenham James Lind Benjamin Jesty Edward Jenner Ignaz Semmelweis John Snow Louis...

Quiz 2 Hippocrates Thomas Sydenham James Lind Benjamin Jesty Edward Jenner Ignaz Semmelweis John Snow Louis Pasteur Robert Koch John Graunt William Farr Bernardino Ramazzini Edgar Sydenstricker Doll and Hill Florence Nightingale Janet Lane-Claypon Alice Hamilton Wade Hampton Frost Identified various modes of transmission and incubation times for cholera B. Provided classifications of morbidity statistics to improve the value of morbidity information C. Observed in the 17th century that certain jobs carried a high risk for disease D. Introduced the...

How will a vaccine against the COVID-19 virus be developed?

Instructions: Find an article relating to technology. Make sure the article is recent (sometime within the...

Instructions: Find an article relating to technology. Make sure the article is recent (sometime within the last 12 months). The article can be describing a study on technology, or a description of a new technology. For example, I saw an interesting article the other day about self-confidence and Facebook. At the top of the first page, include a link to the article. In the first paragraph, summarize the article. In the second paragraph, tell me your opinion of the technology...

Identify and explain the externality associated with a vaccine that is developed to address the COVID-19...

Identify and explain the externality associated with a vaccine that is developed to address the COVID-19 pandemic

Suppose you have developed a coronavirus vaccine and wish to verify that it is effective in...

Suppose you have developed a coronavirus vaccine and wish to verify that it is effective in reducing the probability of being infected with the disease. You obtain two random samples. The control group of 90 people is given a placebo, and after 1 year, 8 of them had been infected. The experimental group received the vaccine. Of the 300 people in the experimental group, 8 of them had been infected after 1 year. (SHOW WORK!) The alternative hypothesis for this...

A new vaccine developed by Very Bad Drug Corp is about to be distributed en masse...

A new vaccine developed by Very Bad Drug Corp is about to be distributed en masse in a Third World country experiencing an epidemic. The vaccine either does nothing or is effective in preventing the disease. The country's leadership doesn't trust First World drug companies and wishes to avoid making the mistake of "believing the drug works when in fact it does nothing". What sort of mistake is this? If you were in charge would you have any tools at...

A Mexican laboratory developed a new vaccine against COVID-19, which should be stored at an average...

A Mexican laboratory developed a new vaccine against COVID-19, which should be stored at an average daily temperature of 8 degrees, with a standard deviation of 3 degrees. If the distribution of daily temperatures is approximately normal. What is the probability that: A) On a given day the temperature would have been between 6 and 9 degrees B) The first day a temperature of at most 7.1 degrees is reached is before 6 days

When the chickenpox vaccine was developed older people who had not had chickenpox were among the...

When the chickenpox vaccine was developed older people who had not had chickenpox were among the first to be able to get the vaccine. However, sometimes people have such a minor chickenpox infection that it goes unnoticed, yet still generates complete adaptive immunity. Before giving the vaccine, healthcare workers would test potential recipients to see if they already had chickenpox and had immunity to the virus. Describe how you could develop an ELISA test to determine if someone had immunity...

2. A new flu vaccine was developed to protect elderly people against viral infection during the...

2. A new flu vaccine was developed to protect elderly people against viral infection during the winter season. In 120 patients, 70 of the patients who were vaccinated. Of the 70 patients, 56 of the patients had no flu symptoms. 50 of the patients who were not vaccinated, 28 patients have no flu symptoms. a) Determine the confidence interval (CI) at 95% (z*=1.96) level for the probability that a patient had no flu symptoms when a new vaccine is used...

Subjects